|
|
||||||||||||||
|
|
|||||||||||||||
RESEARCH ETHICS |
1 Family Health International, PO Box 13951, Research Triangle Park, NC, USA
2 Department of Medicine and Bioethics Centre, University of Cape Town Observatory, 7925, Cape, South Africa
Correspondence to:
S R Benatar
Department of Medicine & Bioethics Centre, University of Cape Town Observatory, 7925, Cape, South Africa; sbenatar{at}uctgsh1.uct.ac.za
Intensification of poverty and degradation of health infrastructure over recent decades in countries most affected by HIV/AIDS present formidable challenges to clinical research. This paper addresses the overall standard of health care (SOC) that should be provided to research participants in developing countries, rather than the narrow definition of SOC that has characterised the international debate on standards of health care. It argues that contributing to sustainable improvements in health by progressively ratcheting the standard of care upwards for research participants and their communities is an ethical obligation of those in resource-rich countries who sponsor and implement research in poorer ones.
Keywords: global inequality; HIV; moral progress; prevention research; standard of care
This article has been cited by other articles:
![]() |
H. S. Richardson Gradations of Researchers' Obligation to Provide Ancillary Care for HIV/AIDS in Developing Countries Am J Public Health, November 1, 2007; 97(11): 1956 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weijer and G. J. LeBlanc The Balm of Gilead: Is the Provision of Treatment to those Who Seroconvert in HIV Prevention Trials a Matter of Moral Obligation or Moral Negotiation? J. Law Med. Ethics, December 1, 2006; 34(4): 793 - 808. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |